Anew Health Statistics
Total Valuation
Anew Health has a market cap or net worth of $259.00 million. The enterprise value is $251.02 million.
| Market Cap | 259.00M |
| Enterprise Value | 251.02M |
Important Dates
The last earnings date was Wednesday, September 24, 2025.
| Earnings Date | Sep 24, 2025 |
| Ex-Dividend Date | May 29, 2025 |
Share Statistics
Anew Health has 51.80 million shares outstanding.
| Current Share Class | 32.67M |
| Shares Outstanding | 51.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.54% |
| Owned by Institutions (%) | 70.48% |
| Float | 25.73M |
Valuation Ratios
The trailing PE ratio is 26.54 and the forward PE ratio is 18.75.
| PE Ratio | 26.54 |
| Forward PE | 18.75 |
| PS Ratio | 6.27 |
| Forward PS | n/a |
| PB Ratio | 74.04 |
| P/TBV Ratio | 3.08 |
| P/FCF Ratio | 161.21 |
| P/OCF Ratio | 141.99 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 15.97, with an EV/FCF ratio of 156.24.
| EV / Earnings | 25.72 |
| EV / Sales | 6.08 |
| EV / EBITDA | 15.97 |
| EV / EBIT | 19.75 |
| EV / FCF | 156.24 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 0.74 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | 2.59 |
| Interest Coverage | 13.94 |
Financial Efficiency
Return on equity (ROE) is 278.95% and return on invested capital (ROIC) is 137.17%.
| Return on Equity (ROE) | 278.95% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 137.17% |
| Return on Capital Employed (ROCE) | 4.77% |
| Revenue Per Employee | $187,804 |
| Profits Per Employee | $44,356 |
| Employee Count | 220 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 4.78 |
Taxes
In the past 12 months, Anew Health has paid $2.04 million in taxes.
| Income Tax | 2.04M |
| Effective Tax Rate | 17.27% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -64.44% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.10 |
| Relative Strength Index (RSI) | 32.65 |
| Average Volume (20 Days) | 1,870 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Anew Health had revenue of $41.32 million and earned $9.76 million in profits. Earnings per share was $0.19.
| Revenue | 41.32M |
| Gross Profit | 29.58M |
| Operating Income | 12.69M |
| Pretax Income | 11.80M |
| Net Income | 9.76M |
| EBITDA | 15.72M |
| EBIT | 12.71M |
| Earnings Per Share (EPS) | $0.19 |
Full Income StatementBalance Sheet
The company has $12.13 million in cash and $4.16 million in debt, giving a net cash position of $7.98 million or $0.15 per share.
| Cash & Cash Equivalents | 12.13M |
| Total Debt | 4.16M |
| Net Cash | 7.98M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 3.50M |
| Book Value Per Share | 0.07 |
| Working Capital | -4.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.82 million and capital expenditures -$217,430, giving a free cash flow of $1.61 million.
| Operating Cash Flow | 1.82M |
| Capital Expenditures | -217,430 |
| Free Cash Flow | 1.61M |
| FCF Per Share | $0.03 |
Full Cash Flow StatementMargins
Gross margin is 71.58%, with operating and profit margins of 30.72% and 23.62%.
| Gross Margin | 71.58% |
| Operating Margin | 30.72% |
| Pretax Margin | 28.55% |
| Profit Margin | 23.62% |
| EBITDA Margin | 38.06% |
| EBIT Margin | 30.76% |
| FCF Margin | 3.89% |
